Study of AROSOD-1 in Adult Participants With Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT05949294 · WITHDRAWN

Trial details

NCT number: NCT05949294
Sponsor: Arrowhead Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2024-01-01
Primary completion: 2025-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.